Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha
- PMID: 18251167
Risk factors associated with non-alcoholic fatty liver disease in Chinese patients and the role of tumor necrosis factor-alpha
Abstract
Background/aims: Tumor necrosis factor-alpha (TNFalpha) has been reported to be associated with insulin resistance and induce inflammatory cytokines formation. Previous studies in human and animals showed inhibition of TNF-alpha improved severity of non-alcoholic fatty liver disease (NAFLD). The aims of this study were to measure plasma levels of TNFalpha in NAFLD and healthy subjects and investigate potential risk factors.
Methodology: A total of 144 patients (90 NAFLD, 50 controls) were enrolled. Clinical and laboratory data of each patient were collected. Plasma levels of TNF-alpha were measured with a commercially available solid phase sandwich enzyme-linked immunosorbent assay (R&D systems, USA). The lower detection limit of this assay was 0.12 pg/mL.
Results: Multivariate analyses showed elevated triglyceride (odds ratio: 7.30, p<0.001) and BMI >25 kg/m2 (odds ratio: 3.57, p<0.005) were the two factors associated with NAFLD. Mean plasma level of TNF-alpha was significantly higher in NAFLD patients with abnormal ALT than controls (2.63+/-0.44 pg/mL vs. 1.56+/-0.10 pg/mL, p=0.016). Modest correlations were noted between plasma levels of TNF-alpha with ALT (r=0.25, p<0.005) and triglyceride (r=0.40, p<0.001).
Conclusions: TNF-alpha may participate in the pathogenesis of NAFLD. Inhibition of TNF-alpha activity by drugs or antibodies may be a potential approach to treat NAFLD patients.
Similar articles
-
Association of tumor necrosis factor-α gene promoter polymorphism at sites -308 and -238 with non-alcoholic fatty liver disease: a meta-analysis.J Gastroenterol Hepatol. 2012 Apr;27(4):670-6. doi: 10.1111/j.1440-1746.2011.06978.x. J Gastroenterol Hepatol. 2012. PMID: 22097889 Review.
-
Plasma interleukin-18/interleukin-18 binding protein ratio in Chinese with NAFLD.Hepatogastroenterology. 2010 Jan-Feb;57(97):103-6. Hepatogastroenterology. 2010. PMID: 20422882
-
Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.Clin Infect Dis. 2008 Jul 15;47(2):250-7. doi: 10.1086/589294. Clin Infect Dis. 2008. PMID: 18532884
-
Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.Cytokine. 2006 Mar 7;33(5):252-7. doi: 10.1016/j.cyto.2006.02.006. Epub 2006 Mar 27. Cytokine. 2006. PMID: 16564703
-
Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease.Clin Liver Dis. 2004 Aug;8(3):619-38, x. doi: 10.1016/j.cld.2004.04.012. Clin Liver Dis. 2004. PMID: 15331067 Review.
Cited by
-
The association of Neuromedin U levels and non-alcoholic fatty liver disease: A comparative analysis.Heliyon. 2024 Mar 5;10(5):e27291. doi: 10.1016/j.heliyon.2024.e27291. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38486771 Free PMC article.
-
Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study.Front Endocrinol (Lausanne). 2023 Aug 9;14:1215790. doi: 10.3389/fendo.2023.1215790. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37621646 Free PMC article.
-
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.Diagnostics (Basel). 2022 Feb 4;12(2):407. doi: 10.3390/diagnostics12020407. Diagnostics (Basel). 2022. PMID: 35204498 Free PMC article. Review.
-
Therapeutic Effects of Resveratrol on Nonalcoholic Fatty Liver Disease Through Inflammatory, Oxidative Stress, Metabolic, and Epigenetic Modifications.Methods Mol Biol. 2022;2343:19-35. doi: 10.1007/978-1-0716-1558-4_2. Methods Mol Biol. 2022. PMID: 34473313
-
Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis.Clin Interv Aging. 2018 Oct 4;13:1879-1891. doi: 10.2147/CIA.S170533. eCollection 2018. Clin Interv Aging. 2018. PMID: 30323574 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical